|
TOB2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.45699999632276E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.167000E-04 |
| Normal-vs-Stage2 |
3.35689999997335E-06 |
| Normal-vs-Stage3 |
7.78089814801319E-11 |
| Normal-vs-Stage4 |
1.68121072618987E-12 |
| Stage1-vs-Stage2 |
4.339700E-02 |
| Stage1-vs-Stage3 |
2.09299999999191E-05 |
| Stage1-vs-Stage4 |
7.31740001924663E-09 |
| Stage2-vs-Stage3 |
3.570400E-01 |
| Stage2-vs-Stage4 |
3.199600E-02 |
| Stage3-vs-Stage4 |
1.372230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.06719999796113E-08 |
| Normal-vs-AfricanAmerican |
4.62619999996861E-06 |
| Normal-vs-Asian |
4.064200E-01 |
| Caucasian-vs-AfricanAmerican |
4.523600E-01 |
| Caucasian-vs-Asian |
2.599200E-01 |
| AfricanAmerican-vs-Asian |
1.925970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.15650045096061E-10 |
| Normal-vs-Female |
5.793500E-04 |
| Male-vs-Female |
1.824830E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.47319999996587E-06 |
| Normal-vs-Age(41-60Yrs) |
2.91240000005466E-06 |
| Normal-vs-Age(61-80Yrs) |
5.49140000138948E-08 |
| Normal-vs-Age(81-100Yrs) |
2.518100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.330100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.271400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.002800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.323000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.022600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.607600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.377200E-01 |
| Normal-vs-Grade 2 |
4.812200E-04 |
| Normal-vs-Grade 3 |
1.76670000850976E-09 |
| Normal-vs-Grade 4 |
1.62481139653892E-12 |
| Grade 1-vs-Grade 2 |
1.439970E-02 |
| Grade 1-vs-Grade 3 |
3.198400E-04 |
| Grade 1-vs-Grade 4 |
9.642500E-04 |
| Grade 2-vs-Grade 3 |
1.249870E-04 |
| Grade 2-vs-Grade 4 |
2.22366569602173E-12 |
| Grade 3-vs-Grade 4 |
3.850000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.213600E-01 |
| Normal-vs-ccB subtype |
1.62436730732907E-12 |
| ccA subtype-vs-ccB subtype |
1.6242562850266E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.78890000035459E-07 |
| Normal-vs-N1 |
2.01180000003465E-06 |
| N0-vs-N1 |
1.965970E-02 |
|
|
